Ballentine Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.41M | Sell |
|
|||||
|
2025
Q2 | $7.6M | Sell |
|
|||||
|
2025
Q1 | $8.87M | Buy |
|
|||||
|
2024
Q4 | $6.68M | Buy |
|
|||||
|
2024
Q3 | $7.42M | Buy |
|
|||||
|
2024
Q2 | $5.49M | Buy |
|
|||||
|
2024
Q1 | $5.7M | Buy |
|
|||||
|
2023
Q4 | $3.93M | Sell |
|
|||||
|
2023
Q3 | $4.14M | Buy |
|
|||||
|
2023
Q2 | $2.7M | Sell |
|
|||||
|
2023
Q1 | $4.18M | Buy |
|
|||||
|
2022
Q4 | $3.16M | Buy |
|
|||||
|
2022
Q3 | $2.37M | Buy |
|
|||||
|
2022
Q2 | $2.28M | Buy |
|
|||||
|
2022
Q1 | $2.38M | Sell |
|
|||||
|
2021
Q4 | $1.99M | Buy |
|
|||||
|
2021
Q3 | $1.42M | Buy |
|
|||||
|
2021
Q2 | $1.48M | Buy |
|
|||||
|
2021
Q1 | $1.33M | Buy |
|
|||||
|
2020
Q4 | $1.24M | Sell |
|
|||||
|
2020
Q3 | $1.24M | Buy |
|
|||||
|
2020
Q2 | $1.34M | Buy |
|
|||||
|
2020
Q1 | $951K | Buy |
|
|||||
|
2019
Q4 | $1.09M | Buy |
|
|||||
|
2019
Q3 | $922K | Buy |
|
|||||
|
2019
Q2 | $886K | Buy |
|
|||||
|
2019
Q1 | $645K | Sell |
|
|||||
|
2018
Q4 | $844K | Buy |
|
|||||
|
2018
Q3 | $806K | Buy |
|
|||||
|
2018
Q2 | $719K | Buy |
|
|||||
|
2018
Q1 | $653K | Hold |
|
|||||
|
2017
Q4 | $667K | Sell |
|
|||||
|
2017
Q3 | $720K | Sell |
|
|||||
|
2017
Q2 | $822K | Buy |
|
|||||
|
2017
Q1 | $428K | Sell |
|
|||||
|
2016
Q4 | $523K | Buy |
|
|||||
|
2016
Q3 | $459K | Sell |
|
|||||
|
2016
Q2 | $486K | Buy |
|
|||||
|
2016
Q1 | $410K | Buy |
|
|||||
|
2015
Q4 | $411K | Buy |
|
|||||
|
2015
Q3 | $359K | Sell |
|
|||||
|
2015
Q2 | $446K | Buy |
|
|||||
|
2015
Q1 | $387K | Sell |
|
|||||
|
2014
Q4 | $438K | Hold |
|
|||||
|
2014
Q3 | $387K | Buy |
|
|||||
|
2014
Q2 | $377K | Sell |
|
|||||
|
2014
Q1 | $358K | Buy |
|
|||||
|
2013
Q4 | $360K | Hold |
|
|||||
|
2013
Q3 | $305K | Buy |
|
|||||
|
2013
Q2 | $203K | Buy |
|